MK-6482 Receives Breakthrough Therapy Designation for VHL-Related RCC
Photo by Robina Weermeijer on Unsplash

MK-6482 Receives Breakthrough Therapy Designation for VHL-Related RCC

  According to Ryan McDonald of Cure Today, the FDA recently granted Breakthrough Therapy Designation to MK-6482, an investigational HIF-2α inhibitor developed by Merck. The orally-administered drug, designed to treat…

Continue Reading MK-6482 Receives Breakthrough Therapy Designation for VHL-Related RCC
Warrior Princess: Fighting with a Rare Disease Under Unprecedented Circumstances, Part Three
source: pixabay.com

Warrior Princess: Fighting with a Rare Disease Under Unprecedented Circumstances, Part Three

Continued From Part Two Written by Payel Bhattacharya   I hope for aid from the government to cover the high cost of subsequent medicines including anti-rejection medicines, radiological and lab…

Continue Reading Warrior Princess: Fighting with a Rare Disease Under Unprecedented Circumstances, Part Three
Warrior Princess: Fighting a Rare Disease Under Unprecedented Circumstances, Part Two
source: pixabay.com

Warrior Princess: Fighting a Rare Disease Under Unprecedented Circumstances, Part Two

Continued From Part One written by Payel Bhattacharya Pharmaceutical science has medications to control the pain. I was initially put on medicine but it mostly didn’t contain the pain. I…

Continue Reading Warrior Princess: Fighting a Rare Disease Under Unprecedented Circumstances, Part Two

Warrior Princess: Fighting with a Rare Disease Under Unprecedented Circumstances, Part One

By Payel Bhattacharya, living with von Hippel-Lindau syndrome I, Miss Payel Bhattacharya, was an unusual child. I was never concerned with petty things, the trivia, the dregs in life. My…

Continue Reading Warrior Princess: Fighting with a Rare Disease Under Unprecedented Circumstances, Part One
Recent Research Into The Nature of Von Hippel-Lindau Syndrome Could Be a Path To New Treatments
source: pixabay.com

Recent Research Into The Nature of Von Hippel-Lindau Syndrome Could Be a Path To New Treatments

According to an article from the Augusta Free Press, a research team from Vanderbilt University and the Virginia Tech Carilion Research Institute has successfully managed to uncover the manner in…

Continue Reading Recent Research Into The Nature of Von Hippel-Lindau Syndrome Could Be a Path To New Treatments
Close Menu